Sabin S Egger
Impact in
- Geriatrics and Gerontology top 1%
- Pharmaceutical Practices and Patient Outcomes
- Family Practice top 5%
- Medication Adherence and Compliance
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 5
-
- Drug-Induced Hepatotoxicity and Protection 3
- Pharmacogenetics and Drug Metabolism 3
- Drug-Induced Adverse Reactions 3
- Co-authors
- Raymond G. Schlienger (4 shared papers)Jürgen Drewe (3 shared papers)Stephan Kr henb hl (2 shared papers)Stephan Krähenbühl (6 shared papers)Alexandra E. Rätz Bravo (3 shared papers)Lorenzo Hess (1 shared paper)Stephan Krähenbühl (2 shared papers)Lydia Tchambaz (1 shared paper)
- Journals
- European Journal of Clinical Pharmacology (3 papers)Drugs & Aging (2 papers)Annals of Pharmacotherapy (2 papers)Drug Safety (1 paper)Bone Marrow Transplantation (1 paper)
- Partner nations
- SwitzerlandUnited StatesSpain
In The Last Decade
Sabin S Egger
13 papers receiving 453 citations
Peers
Comparison fields: 5 of 79
- Geriatrics and Gerontology 255
- Family Practice 55
- Toxicology 64
- Pharmacology 117
- Hepatology 62
Countries citing papers authored by Sabin S Egger
This map shows the geographic impact of Sabin S Egger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabin S Egger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabin S Egger more than expected).
Fields of papers citing papers by Sabin S Egger
This network shows the impact of papers produced by Sabin S Egger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabin S Egger. The network helps show where Sabin S Egger may publish in the future.
Co-authors
The 16 scholars most cited alongside Sabin S Egger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 154 | |
| 2 | 2006 | 85 | |
| 3 | 2007 | 56 | |
| 4 | 2011 | 53 | |
| 5 | 2013 | 42 | |
| 6 | 2009 | 26 | |
| 7 | 2009 | 22 | |
| 8 | 2004 | 11 | |
| 9 | 2006 | 6 | |
| 10 | 2005 | 4 | |
| 11 | 2010 | 2 | |
| 12 | 2005 | 1 | |
| 13 | [Dealing with adverse drug reactions in dentistry. Procedures on encountering adverse drug reactions and goal of the Swiss Pharmacovigilance system]. | 2005 | 1 |
About Sabin S Egger
Sabin S Egger is a scholar working on Geriatrics and Gerontology, Pharmacology, Surgery, Pharmacology and Epidemiology, having authored 13 papers that have together received 463 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (5 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Drug-Induced Adverse Reactions (3 papers), Pharmaceutical studies and practices (2 papers), Liver Disease and Transplantation (2 papers), Intestinal Malrotation and Obstruction Disorders (1 paper) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper). The work is most often cited by research in Geriatrics and Gerontology (255 citations), Family Practice (55 citations), Toxicology (64 citations), Pharmacology (117 citations) and Hepatology (62 citations). Sabin S Egger has collaborated with scholars based in Switzerland, United States and Spain. Frequent co-authors include Raymond G. Schlienger, Jürgen Drewe, Stephan Kr henb hl, Stephan Krähenbühl, Alexandra E. Rätz Bravo, Lorenzo Hess, Stephan Krähenbühl, Lydia Tchambaz, Stéphanie Meier and Manuel Haschke. Their work appears in journals such as European Journal of Clinical Pharmacology, Drugs & Aging, Annals of Pharmacotherapy, Drug Safety and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.